Logo image of ACTG

ACACIA RESEARCH CORP (ACTG) Stock Fundamental Analysis

NASDAQ:ACTG - Nasdaq - US0038813079 - Common Stock - Currency: USD

2.89  -0.05 (-1.7%)

After market: 2.89 0 (0%)

Fundamental Rating

2

Overall ACTG gets a fundamental rating of 2 out of 10. We evaluated ACTG against 101 industry peers in the Financial Services industry. The financial health of ACTG is average, but there are quite some concerns on its profitability. ACTG has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ACTG has reported negative net income.
ACTG had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ACTG reported negative net income in multiple years.
In multiple years ACTG reported negative operating cash flow during the last 5 years.
ACTG Yearly Net Income VS EBIT VS OCF VS FCFACTG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M -150M

1.2 Ratios

ACTG has a Return On Assets of -4.77%. This is amonst the worse of the industry: ACTG underperforms 87.13% of its industry peers.
The Return On Equity of ACTG (-7.00%) is worse than 81.19% of its industry peers.
Industry RankSector Rank
ROA -4.77%
ROE -7%
ROIC N/A
ROA(3y)-7.87%
ROA(5y)1.65%
ROE(3y)-15.04%
ROE(5y)2.47%
ROIC(3y)N/A
ROIC(5y)N/A
ACTG Yearly ROA, ROE, ROICACTG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

With a decent Gross Margin value of 42.94%, ACTG is doing good in the industry, outperforming 65.35% of the companies in the same industry.
In the last couple of years the Gross Margin of ACTG has declined.
ACTG does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.92%
GM growth 5Y-5.27%
ACTG Yearly Profit, Operating, Gross MarginsACTG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200 -200

5

2. Health

2.1 Basic Checks

ACTG does not have a ROIC to compare to the WACC, probably because it is not profitable.
ACTG has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, ACTG has more shares outstanding
Compared to 1 year ago, ACTG has a worse debt to assets ratio.
ACTG Yearly Shares OutstandingACTG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ACTG Yearly Total Debt VS Total AssetsACTG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

Based on the Altman-Z score of 0.84, we must say that ACTG is in the distress zone and has some risk of bankruptcy.
ACTG has a Altman-Z score of 0.84. This is comparable to the rest of the industry: ACTG outperforms 56.44% of its industry peers.
A Debt/Equity ratio of 0.22 indicates that ACTG is not too dependend on debt financing.
ACTG has a better Debt to Equity ratio (0.22) than 65.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Altman-Z 0.84
ROIC/WACCN/A
WACC8.64%
ACTG Yearly LT Debt VS Equity VS FCFACTG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

ACTG has a Current Ratio of 8.89. This indicates that ACTG is financially healthy and has no problem in meeting its short term obligations.
ACTG's Current ratio of 8.89 is amongst the best of the industry. ACTG outperforms 97.03% of its industry peers.
ACTG has a Quick Ratio of 8.31. This indicates that ACTG is financially healthy and has no problem in meeting its short term obligations.
ACTG's Quick ratio of 8.31 is amongst the best of the industry. ACTG outperforms 97.03% of its industry peers.
Industry RankSector Rank
Current Ratio 8.89
Quick Ratio 8.31
ACTG Yearly Current Assets VS Current LiabilitesACTG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2

3. Growth

3.1 Past

The earnings per share for ACTG have decreased strongly by -110.13% in the last year.
The Revenue has decreased by -2.22% in the past year.
ACTG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 61.31% yearly.
EPS 1Y (TTM)-110.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-122.58%
Revenue 1Y (TTM)-2.22%
Revenue growth 3Y11.6%
Revenue growth 5Y61.31%
Sales Q2Q%-47.14%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-167.75%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year84.79%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACTG Yearly Revenue VS EstimatesACTG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
ACTG Yearly EPS VS EstimatesACTG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2020 2021 2022 2023 2024 2025 0 2 -2

1

4. Valuation

4.1 Price/Earnings Ratio

ACTG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ACTG is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACTG Price Earnings VS Forward Price EarningsACTG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ACTG is valued cheaply inside the industry as 97.03% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.77
ACTG Per share dataACTG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ACTG!.
Industry RankSector Rank
Dividend Yield N/A

ACACIA RESEARCH CORP

NASDAQ:ACTG (4/17/2025, 8:00:46 PM)

After market: 2.89 0 (0%)

2.89

-0.05 (-1.7%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)03-13 2025-03-13/bmo
Earnings (Next)05-08 2025-05-08
Inst Owners87.48%
Inst Owner Change0.09%
Ins Owners1.1%
Ins Owner Change-0.4%
Market Cap288.67M
Analysts82.86
Price Target6.12 (111.76%)
Short Float %1.33%
Short Ratio6.98
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-772.06%
Min EPS beat(2)-1472.55%
Max EPS beat(2)-71.57%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-7.97%
Min Revenue beat(2)-16.14%
Max Revenue beat(2)0.2%
Revenue beat(4)3
Avg Revenue beat(4)32.27%
Min Revenue beat(4)-16.14%
Max Revenue beat(4)116.76%
Revenue beat(8)5
Avg Revenue beat(8)140.38%
Revenue beat(12)7
Avg Revenue beat(12)96.1%
Revenue beat(16)10
Avg Revenue beat(16)165.09%
PT rev (1m)0%
PT rev (3m)-14.29%
EPS NQ rev (1m)-20%
EPS NQ rev (3m)-100%
EPS NY rev (1m)4.55%
EPS NY rev (3m)4.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.36
P/FCF N/A
P/OCF 5.76
P/B 0.56
P/tB 0.67
EV/EBITDA 1.77
EPS(TTM)-0.08
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)-1.13
FCFYN/A
OCF(TTM)0.5
OCFY17.36%
SpS1.22
BVpS5.15
TBVpS4.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.77%
ROE -7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.94%
FCFM N/A
ROA(3y)-7.87%
ROA(5y)1.65%
ROE(3y)-15.04%
ROE(5y)2.47%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.92%
GM growth 5Y-5.27%
F-Score3
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.22
Debt/FCF N/A
Debt/EBITDA 22.41
Cap/Depr 484.5%
Cap/Sales 132.99%
Interest Coverage N/A
Cash Conversion 985.49%
Profit Quality N/A
Current Ratio 8.89
Quick Ratio 8.31
Altman-Z 0.84
F-Score3
WACC8.64%
ROIC/WACCN/A
Cap/Depr(3y)189.58%
Cap/Depr(5y)211.52%
Cap/Sales(3y)49.19%
Cap/Sales(5y)43.71%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-110.13%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-122.58%
EPS Next Y-167.75%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.22%
Revenue growth 3Y11.6%
Revenue growth 5Y61.31%
Sales Q2Q%-47.14%
Revenue Next Year84.79%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-189.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year219.05%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-292.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y322.71%
OCF growth 3Y55.62%
OCF growth 5YN/A